About DarioHealth Corp.

DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. It offers a monitoring device, mobile application, and data services for diabetes management. Its solutions include MyDario, Daro Engage, and Dario Intelligence. The company was founded by Oren Fuerst, Shoshana Friedman, David Weintraub, Dov Oppenheim, and Shilo Ben Zeev on August 11, 2011 and is headquartered in Caesarea, Israel.

At the moment the company generates 7M USD in revenues.

On its last earning announcement, the company reported a loss of -7.80$ per share.

The book value per share is 1.79$

DarioHealth Corp. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
7M 26.50% -18M -247.30% -19M -7.80 - - 2M 1.79 -16M - -16M